HROW · Harrow, Inc.
Market Cap
$1.39B
Shares
37.49M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$36.97
Open$36.79
Day$36.62–37.49
52W close$29.03–54.80
Avg vol 30d526K
Short int6.4M · 17.0% float · 10.3d
Short vol65%
Last earningsAug 11, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 10
Up next
Next earnings call
Nov 12, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 10, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−11%
below
Price vs 50-day avg
−10%
below
RSI (14)
39
neutral
MACD trend
Negative
52-week position
31%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−7%
trailing
6-month return
0%
trailing
YTD return
−25%
this year
Relative strength
−13%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $41 › 200d $41 — 200d above 50d
Institutional flow
Accumulating
+1% holders QoQ · +41 funds added
Insider flow
Distributing
Net -$450.0K over 90 days · 100% sells
Short interest
Falling
16.96% of float · ▼ -6.3% MoM · 10.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
224 holders — near 3-yr high, broad support
Squeeze score
71
high risk · 0–100
Fundamentals
Revenue growth
+36%
Y/Y
Gross margin
75%
contracting
EPS growth
+71%
Y/Y
Free cash flow
$43.0M
Balance sheet
$177.1M
net debt
Quant / Vol
risk profile
Volatility
65%
annualized · 1-yr
Max drawdown
−47%
past year
ATR
5.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−11%
Bearish
Price vs 50-day avg
−10%
Bearish
RSI (14)
39
Neutral
MACD trend
Negative
Bearish
52-week position
31%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
Death cross
50d $41 › 200d $41 — 200d above 50d
Institutional flow
Accumulating
+1% holders QoQ · +41 funds added
Insider flow
Distributing
Net -$450.0K over 90 days · 100% sells
Short interest
Falling
16.96% of float · ▼ -6.3% MoM · 10.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
224 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $29
Now $37 · 31%
Range high $55
vs 200-day avg -11%
vs 50-day avg -10%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HROW
this stock
Harrow, Inc.
|
$1.39B | -24.6% | +36.4% | — | 17.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$58.66B | +16.9% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$47.69B | -1.4% | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.35B | -0.4% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HROW | -10.6% | -7.2% | +0.1% | +0.2% | -24.6% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | -10.0% | -5.9% | -12.6% | +0.9% | -36.3% |
Key facts
CIK
1360214
CUSIP
415858109
13F (30d)
183 filings
179 filers
Visit website
Investor relations